tradingkey.logo

Mesa Laboratories Inc

MLAB
80.470USD
-0.200-0.25%
收盘 12/26, 16:00美东报价延迟15分钟
443.45M总市值
亏损市盈率 TTM

Mesa Laboratories Inc

80.470
-0.200-0.25%

关于 Mesa Laboratories Inc 公司

Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.

Mesa Laboratories Inc简介

公司代码MLAB
公司名称Mesa Laboratories Inc
上市日期Feb 29, 1984
CEOOwens (Gary M)
员工数量730
证券类型Ordinary Share
年结日Feb 29
公司地址12100 W 6th Ave
城市LAKEWOOD
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编80228
电话13039878000
网址https://mesalabs.com
公司代码MLAB
上市日期Feb 29, 1984
CEOOwens (Gary M)

Mesa Laboratories Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Gary M. Owens
Mr. Gary M. Owens
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
148.26K
+8.45%
Dr. John James Sullivan, Ph.D.
Dr. John James Sullivan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
70.06K
-2.78%
Mr. John V. Sakys
Mr. John V. Sakys
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
41.70K
+31.03%
Mr. Brian Archbold
Mr. Brian Archbold
Senior Vice President - Continuous Improvement
Senior Vice President - Continuous Improvement
--
--
Mr. Shiraz S. Ladiwala
Mr. Shiraz S. Ladiwala
Lead Independent Director
Lead Independent Director
--
--
Mr. Mark Christophe Capone
Mr. Mark Christophe Capone
Independent Director
Independent Director
--
--
Ms. Jennifer S. Alltoft
Ms. Jennifer S. Alltoft
Independent Director
Independent Director
--
--
Mr. R. Tony Tripeny
Mr. R. Tony Tripeny
Independent Director
Independent Director
--
--
Ms. Shannon M. Hall
Ms. Shannon M. Hall
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Gary M. Owens
Mr. Gary M. Owens
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
148.26K
+8.45%
Dr. John James Sullivan, Ph.D.
Dr. John James Sullivan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
70.06K
-2.78%
Mr. John V. Sakys
Mr. John V. Sakys
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
41.70K
+31.03%
Mr. Brian Archbold
Mr. Brian Archbold
Senior Vice President - Continuous Improvement
Senior Vice President - Continuous Improvement
--
--
Mr. Shiraz S. Ladiwala
Mr. Shiraz S. Ladiwala
Lead Independent Director
Lead Independent Director
--
--
Mr. Mark Christophe Capone
Mr. Mark Christophe Capone
Independent Director
Independent Director
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Discrete Revenues- Consumables
35.77M
60.08%
Discrete Revenues- Hardware and Software
12.57M
21.11%
Contracted Revenues- Services
7.90M
13.26%
Discrete Revenues- Services
3.31M
5.55%
地区USD
名称
营收
占比
United States
27.65M
46.43%
Other
26.47M
44.45%
China
5.43M
9.12%
业务
地区
业务USD
名称
营收
占比
Discrete Revenues- Consumables
35.77M
60.08%
Discrete Revenues- Hardware and Software
12.57M
21.11%
Contracted Revenues- Services
7.90M
13.26%
Discrete Revenues- Services
3.31M
5.55%

股东统计

更新时间: 11月16日 周日
更新时间: 11月16日 周日
持股股东
股东类型
持股股东
持股股东
占比
Conestoga Capital Advisors, LLC
7.72%
BlackRock Institutional Trust Company, N.A.
5.93%
The Vanguard Group, Inc.
5.83%
Ranger Investment Management, L.P.
3.80%
Geneva Capital Management LLC
3.47%
其他
73.26%
持股股东
持股股东
占比
Conestoga Capital Advisors, LLC
7.72%
BlackRock Institutional Trust Company, N.A.
5.93%
The Vanguard Group, Inc.
5.83%
Ranger Investment Management, L.P.
3.80%
Geneva Capital Management LLC
3.47%
其他
73.26%
股东类型
持股股东
占比
Investment Advisor
37.82%
Investment Advisor/Hedge Fund
35.41%
Hedge Fund
13.57%
Individual Investor
5.44%
Research Firm
4.14%
Bank and Trust
0.88%
Pension Fund
0.84%
Sovereign Wealth Fund
0.06%
Insurance Company
0.03%
其他
1.82%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
387
5.12M
92.75%
-722.23K
2025Q2
399
5.60M
101.85%
-541.53K
2025Q1
415
5.83M
106.86%
-307.02K
2024Q4
405
5.76M
105.94%
-86.00K
2024Q3
413
5.30M
97.90%
-538.92K
2024Q2
412
5.31M
98.26%
-376.30K
2024Q1
404
5.28M
97.81%
-366.78K
2023Q4
400
5.27M
97.82%
-295.14K
2023Q3
392
5.33M
99.02%
-178.63K
2023Q2
390
5.31M
98.92%
-355.72K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Conestoga Capital Advisors, LLC
566.15K
10.29%
-5.21K
-0.91%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
708.66K
12.88%
-30.52K
-4.13%
Jun 30, 2025
The Vanguard Group, Inc.
388.10K
7.05%
+4.80K
+1.25%
Jun 30, 2025
Ranger Investment Management, L.P.
214.29K
3.9%
-16.70K
-7.23%
Jun 30, 2025
Geneva Capital Management LLC
199.09K
3.62%
+9.78K
+5.17%
Jun 30, 2025
Royce Investment Partners
247.61K
4.5%
-23.51K
-8.67%
Jun 30, 2025
Owens (Gary M)
136.70K
2.48%
+13.43K
+10.89%
Jun 21, 2025
Janus Henderson Investors
113.28K
2.06%
+32.54K
+40.30%
Jun 30, 2025
Atlanta Capital Management Company, L.L.C.
145.94K
2.65%
-1.85K
-1.25%
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月2日 周二
更新时间: 12月2日 周二
机构名称
占比
VictoryShares Small Cap Free Cash Flow ETF
0.22%
Principal U.S. Small-Cap ETF
0.1%
Vanguard US Quality Factor ETF
0.09%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.08%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.06%
WisdomTree US SmallCap Fund
0.05%
Avantis US Small Cap Equity ETF
0.05%
WisdomTree U.S. SmallCap Dividend Fund
0.05%
Invesco Russell 2000 Dynamic Multifactor ETF
0.02%
iShares Russell 2000 Growth ETF
0.02%
查看更多
VictoryShares Small Cap Free Cash Flow ETF
占比0.22%
Principal U.S. Small-Cap ETF
占比0.1%
Vanguard US Quality Factor ETF
占比0.09%
SPDR SSGA US Small Cap Low Volatility Index ETF
占比0.08%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.06%
WisdomTree US SmallCap Fund
占比0.05%
Avantis US Small Cap Equity ETF
占比0.05%
WisdomTree U.S. SmallCap Dividend Fund
占比0.05%
Invesco Russell 2000 Dynamic Multifactor ETF
占比0.02%
iShares Russell 2000 Growth ETF
占比0.02%

分红派息

近5年累计派现 16.82M 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Oct 03, 2025
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Dec 15, 2025 going ex on Nov 28, 2025
Nov 28, 2025
Dec 15, 2025
Nov 28, 2025
Jul 03, 2025
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Sep 15, 2025 going ex on Aug 29, 2025
Aug 29, 2025
Sep 15, 2025
Aug 29, 2025
Apr 07, 2025
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Jun 16, 2025 going ex on May 30, 2025
May 30, 2025
Jun 16, 2025
May 30, 2025
Jan 08, 2025
MLAB.NB Final Cash Dividend of gross USD 0.16 paid on Mar 17, 2025 going ex on Feb 28, 2025
Feb 28, 2025
Mar 17, 2025
Feb 28, 2025
Oct 02, 2024
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Dec 16, 2024 going ex on Nov 29, 2024
Nov 29, 2024
Dec 16, 2024
Nov 29, 2024
Jul 10, 2024
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Sep 16, 2024 going ex on Aug 30, 2024
Aug 30, 2024
Sep 16, 2024
Aug 30, 2024
Apr 05, 2024
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Jun 14, 2024 going ex on May 31, 2024
May 31, 2024
Jun 14, 2024
May 31, 2024
Jan 04, 2024
MLAB.NB Final Cash Dividend of gross USD 0.16 paid on Mar 15, 2024 going ex on Feb 28, 2024
Feb 29, 2024
Mar 15, 2024
Feb 28, 2024
Oct 03, 2023
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Dec 15, 2023 going ex on Nov 29, 2023
Nov 30, 2023
Dec 15, 2023
Nov 29, 2023
Jul 05, 2023
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Sep 15, 2023 going ex on Aug 30, 2023
Aug 31, 2023
Sep 15, 2023
Aug 30, 2023
查看更多

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Mesa Laboratories Inc的前五大股东是谁?

Mesa Laboratories Inc 的前五大股东如下:
Conestoga Capital Advisors, LLC持有股份:566.15K,占总股份比例:10.29%。
BlackRock Institutional Trust Company, N.A.持有股份:708.66K,占总股份比例:12.88%。
The Vanguard Group, Inc.持有股份:388.10K,占总股份比例:7.05%。
Ranger Investment Management, L.P.持有股份:214.29K,占总股份比例:3.90%。
Geneva Capital Management LLC持有股份:199.09K,占总股份比例:3.62%。

Mesa Laboratories Inc的前三大股东类型是什么?

Mesa Laboratories Inc 的前三大股东类型分别是:
Conestoga Capital Advisors, LLC
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.

有多少机构持有Mesa Laboratories Inc(MLAB)的股份?

截至2025Q3,共有387家机构持有Mesa Laboratories Inc的股份,合计持有的股份价值约为5.12M,占公司总股份的92.75%。与2025Q2相比,机构持股有所增加,增幅为-9.10%。

哪个业务部门对Mesa Laboratories Inc的收入贡献最大?

在FY2026Q1,Discrete Revenues- Consumables业务部门对Mesa Laboratories Inc的收入贡献最大,创收35.77M,占总收入的60.08%。
KeyAI